Take Alexander Tanno, for example. Through the spin-off Hemetron, the ETH alumnus, along with doctoral student Yves Blickenstorfer, is developing a rapid test that is accurate, easy to use and portable. He works closely with the university hospitals in Basel and Zurich and with telemedicine companies. The biomedical engineer hopes that his technology will not only play an important role in overcoming any future pandemics, but also help in tackling the current crisis. He is supported by donors, who have provided him with start-up capital, mentoring and access to ETH labs through a Pioneer Fellowship. ETH Zurich is grateful for your support, which is helping ensure that technology such as this is ready to use as quickly as possible and able to make an innovative contribution to our health.